Given the distinct classification of histological subtypes of breast cancer, only a limited number of studies have documented the risk associated with PALB2 mutations in invasive micropapillary carcinoma of the breast (Erkko et al. 2007; Breast Cancer Association Consortium et al. 2022). This evidence concerns the gene PALB2 and breast cancer.